| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 3,826,700 | 3,139,800 | 1,987,100 | | Cost of Revenue | 1,508,700 | 1,066,100 | 607,400 | | | Gross Profit | 2,318,000 | 2,073,700 | 1,379,700 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,103,900 | 985,700 | 583,500 | | Non Recurring |
-
|
-
|
-
| | Others | 579,200 | 430,800 | 257,800 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 634,900 | 657,200 | 538,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 634,900 | 657,200 | 538,400 | | Interest Expense | 184,100 | 168,600 | 161,700 | | Income Before Tax | 450,800 | 488,600 | 376,700 | | Income Tax Expense | 152,100 | 157,600 | 119,300 | | Minority Interest | (1,800) | (2,300) | (1,300) | | | | Net Income From Continuing Ops | 296,900 | 328,700 | 256,100 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 296,900 | 328,700 | 256,100 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $296,900 | $328,700 | $256,100 |
|
1.48% Nasdaq 
Income Statement
